About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Reliance Life to Acquire Controlling Interest of GeneMedix | Main | The Demise of Enantiomer Patenting? »

December 21, 2006

Article Discusses Premature Licensing of Biotech Products

    By Jason Derry --

Nature Reviews - Drug Discovery Nature Reviews Drug Discovery has published an article relating to potential pitfalls associated with licensing deals between pharmaceutical companies and biotechnology companies.  In particular, the authors discuss the financial considerations of trying to in-license a biotech product in the early stages of clinical development.  The article reviews strategies that biotech and big pharmaceutical companies should consider when thinking about licensing biotech products that have not entered late stage (e.g., Phase II or III clinical trials) development.

Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.

Posted at 02:52 PM in Biotech/Pharma Business, Licensing |

Comments

The comments to this entry are closed.

November 2023

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30    

Categories

Archives

More...